DESTiNED to help.
Developing a groundbreaking new technology capable of reversing tissue and organ calcification, saving billion of lives in the process.
We can help millions of people – every year.
This material has a remarkable combination of flexibility and durability: Elastin is one of the body's most long-lasting component proteins.
Healthy elastin In a 6-year old child
Damaged Elastin in a 90 year old person
Elastin fiber major component of lungs and blood vessels. It expands and contracts to circulate blood and oxygen trough the body. Elastin degrades in everyone over 25, triggering aging in skin, arteries and lungs. Inflammation & stiffening of arteries starts at damaged elastin, leading to cardiovascular and lung diseases.
Damaged elastin fibre weakens skin and arterial walls. lt shows up physically as sagging skin, but it also leads to aneurysms and stroke. Starting in the mid-twenties the body stops replacing elastin fibre. The fibre degrades with age. Neurological acuity, mobility, circulation and breathing are impaired.
Elastin degradation is a leading contributor to heart and lung disease. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.
The platform significantly improves the efficacy of drugs and eliminates side-effects by combining particle design with elastin targeting.
Launch broad therapy
Bring affordable preventive therapy
Orphan indications with severe arterial calcification
Generalized arterial calcification of infancy (GACI) and Pseudoxanthoma elasticum (PXE)
No therapies approved yet and those in development only halt progression of disease
Broad indication such as peripheral artery disease (PAD)
Plaque and calcification at the center of problem
27 Million patients in North America and Europe
Universal platform that targets damaged elastic fiber in connective tissue
Improve safety and efficacy of drugs
By increasing drug concentrations at disease site